Diverse vasopressin V2 receptor functionality underlying partial congenital nephrogenic diabetes insipidus

American Journal of Physiology - Renal Physiology

Volumn 297, Issue 6, 2009, Pages

  Færch, Mia ^a,b   Christensen, Jane H ^a,b   Rittig, Søren ^a   Johansson, Jan Ove ^c   Gregersen, Niels ^a   De Zegher, Francis ^d   Corydon, Thomas J ^b  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b AARHUS UNIVERSITY   (Denmark)

^c SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^d UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

Arginine vasopressin receptor type 2; Heterologous expression; Partial phenotype

Indexed keywords

AMINO ACID; ARGININE; ARGIPRESSIN; CYSTEINE; SERINE; VASOPRESSIN V2 RECEPTOR;

AMINO ACID SEQUENCE; ARTICLE; AVPR2 GENE; CARBOXY TERMINAL SEQUENCE; CELL STRAIN HEK293; CONGENITAL DISORDER; CONTROLLED STUDY; ENDOPLASMIC RETICULUM; GENE; GENETIC VARIABILITY; HUMAN; HUMAN CELL; LIGAND BINDING; NEPHROGENIC DIABETES INSIPIDUS; NUCLEOTIDE SEQUENCE; PARTIAL CONGENITAL NEPHROGENIC DIABETES INSIPIDUS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RECEPTOR INTRINSIC ACTIVITY; SEQUENCE ANALYSIS; SIGNAL TRANSDUCTION;

EID: 71449085230     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00331.2009     Document Type: Article

References (27)

1. Ala Y, Morin D, Mouillac B, Sabatier N, Vargas R, Cotte N, Dechaux M, Antignac C, Arthus MF, Lonergan M, Turner MS, Balestre MN, Alonso G, Hibert M, Barberis C, Hendy GN, Bichet DG, Jard S. Functional studies of twelve mutant V2 vasopressin receptors related to nephrogenic diabetes insipidus: molecular basis of a mild clinical phenotype. J Am Soc Nephrol 9: 1861-1872, 1998.
2. Alvarez R, Daniels DV. A separation method for the assay of adenylylcyclase, intracellular cyclic AMP, and cyclic-AMP phosphodiesterase using tritium-labeled substrates. Anal Biochem 203: 76-82, 1992.
3. Bellot G, Granier S, Bourguet W, Seyer R, Rahmeh R, Mouillac B, Pascal R, Mendre C, Demene H. Structure of the third intracellular loop of the vasopressin V2 receptor and conformational changes upon binding to gC1qR. J Mol Biol 388: 491-507, 2009.
4. Birnbaumer M. Vasopressin receptor mutations and nephrogenic diabetes insipidus. Arch Med Res 30: 465-474, 1999. (Pubitemid 30067560)
5. Birnbaumer M. Vasopressin receptors. Trends Endocrinol Metab 11: 406-410, 2000.
6. Chen CH, Chen WY, Liu HL, Liu TT, Tsou AP, Lin CY, Chao T, Qi Y, Hsiao KJ. Identification of mutations in the arginine vasopressin receptor 2 gene causing nephrogenic diabetes insipidus in Chinese patients. J Hum Genet 47: 66-73, 2002. (Pubitemid 34296656)
7. Christensen JH, Siggaard C, Corydon TJ, Robertson GL, Gregersen N, Bolund L, Rittig S. Differential cellular handling of defective arginine vasopressin (AVP) prohormones in cells expressing mutations of the AVP gene associated with autosomal dominant and recessive familial neurohypophyseal diabetes insipidus. J Clin Endocrinol Metab 89: 4521-4531, 2004. (Pubitemid 39244464)
8. Christensen JH, Siggaard C, Corydon TJ, Robertson GL, Gregersen N, Bolund L, Rittig S. Impaired trafficking of mutated AVP prohormone in cells expressing rare disease genes causing autosomal dominant familial neurohypophyseal diabetes insipidus. Clin Endocrinol (Oxf) 60: 125-136, 2004. (Pubitemid 38183508)
9. Corydon TJ. Characterization of overexpressed mutant proteins in mammalian cells. Methods Mol Biol 232: 183-202, 2003.
10. Corydon TJ, Bross P, Jensen TG, Corydon MJ, Lund TB, Jensen UB, Kim JJ, Gregersen N, Bolund L. Rapid degradation of short-chain acyl-CoA dehydrogenase variants with temperature-sensitive folding defects occurs after import into mitochondria. J Biol Chem 273: 13065-13071, 1998. (Pubitemid 28246872)
11. Corydon TJ, Wilsbech M, Jespersgaard C, Andresen BS, Borglum AD, Pedersen S, Bolund L, Gregersen N, Bross P. Human and mouse mitochondrial orthologs of bacterial ClpX. Mamm Genome 11: 899-905, 2000. (Pubitemid 30745166)
12. Deen PM, Marr N, Kamsteeg EJ, van Balkom BW. Nephrogenic diabetes insipidus. Curr Opin Nephrol Hypertens 9: 591-595, 2000.
13. Faerch M, Christensen JH, Corydon TJ, Kamperis K, de Zegher F, Gregersen N, Robertson GL, Rittig S. Partial nephrogenic diabetes insipidus caused by a novel mutation in the AVPR2 gene. Clin Endocrinol (Oxf) 68: 395-403, 2008. (Pubitemid 351257858)
14. Inaba S, Hatakeyama H, Taniguchi N, Miyamori I. The property of a novel v2 receptor mutant in a patient with nephrogenic diabetes insipidus. J Clin Endocrinol Metab 86: 381-385, 2001. (Pubitemid 32109822)
15. Innamorati G, Sadeghi H, Birnbaumer M. A fully active nonglycosylated V2 vasopressin receptor. Mol Pharmacol 50: 467-473, 1996. (Pubitemid 26303575)
16. Morello JP, Bichet DG. Nephrogenic diabetes insipidus. Annu Rev Physiol 63: 607-630, 2001.
17. Muramatsu T, Suwa M. Statistical analysis and prediction of functional residues effective for GPCR-G-protein coupling selectivity. Protein Eng 19: 277-283, 2006.
18. Oksche A, Leder G, Valet S, Platzer M, Hasse K, Geist S, Krause G, Rosenthal A, Rosenthal W. Variant amino acids in the extracellular loops of murine and human vasopressin V2 receptors account for differences in cell surface expression and ligand affinity. Mol Endocrinol 16: 799-813, 2002. (Pubitemid 34297748)
19. Pasel K, Schulz A, Timmermann K, Linnemann K, Hoeltzenbein M, Jaaskelainen J, Gruters A, Filler G, Schoneberg T. Functional characterization of the molecular defects causing nephrogenic diabetes insipidus in eight families. J Clin Endocrinol Metab 85: 1703-1710, 2000. (Pubitemid 32289522)
20. Postina R, Ufer E, Pfeiffer R, Knoers NV, Fahrenholz F. Misfolded vasopressin V2 receptors caused by extracellular point mutations entail congential nephrogenic diabetes insipidus. Mol Cell Endocrinol 164: 31-39, 2000. (Pubitemid 30665497)
21. Robben JH, Knoers NV, Deen PM. Regulation of the vasopressin V2 receptor by vasopressin in polarized renal collecting duct cells. Mol Biol Cell 15: 5693-5699, 2004. (Pubitemid 39564759)
22. Robben JH, Knoers NV, Deen PM. Cell biological aspects of the vasopressin type 2 receptor and aquaporin 2 water channel in nephrogenic diabetes insipidus. Am J Physiol Renal Physiol 291: F257-F270, 2006.
23. Sadeghi H, Robertson GL, Bichet DG, Innamorati G, Birnbaumer M. Biochemical basis of partial nephrogenic diabetes insipidus phenotypes. Mol Endocrinol 11: 1806-1813, 1997.
24. Schroder M, Kaufman RJ. The mammalian unfolded protein response. Annu Rev Biochem 74: 739-789, 2005.
25. Thibonnier M, Coles P, Thibonnier A, Shoham M. Molecular pharmacology and modeling of vasopressin receptors. Prog Brain Res 139: 179-196, 2002. (Pubitemid 35460889)
26. Ufer E, Postina R, Gorbulev V, Fahrenholz F. An extracellular residue determines the agonist specificity of V2 vasopressin receptors. FEBS Lett 362: 19-23, 1995.
27. Wess J. Molecular basis of receptor/G-protein-coupling selectivity. Pharmacol Ther 80: 231-264, 1998.